IBEX 35
11.032,30 -128,20 (-1,15%) Euro Stoxx 50
4.907,30 -40,43 (-0,82%) Dólar/Euro
1,0697 -0,0009 (-0,09%) Petróleo Brent
85,07 -0,64 (-0,75%) Oro
2.334,70 -34,30 (-1,45%) Bitcoin EUR
60.274,95 +304,04 (+0,51%)
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS)
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
No. 45, Shamian North Street
Liwan District
Guangzhou 510130
China
86 20 6628 1218
https://www.gybys.com.cn
Sector(es): Healthcare
Sector: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 28.048
Descripción
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People's Republic of China and internationally. The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, medical instruments, pharmaceutical products, medical equipment, and healthcare products; and research and development, production, and sale of beverages, food, healthcare products, and other products; and production and sale of pre-packaged food, dairy products, etc., as well as offers herbal tea, tablets, capsules, lozenges, tortoise herb jelly, etc. In addition, the company invests in health industry, such as medical services, health management, health maintenance, elderly care, etc.; and provides leasing and commercial, health, advertising, loading offloading, and warehouse services. It operates through retail chain pharmacy stores and retail stores. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.
Gobierno corporativo
El ISS Governance QualityScore de Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, a día 1 de junio de 2024, es 4. Las puntuaciones base son Auditoría: 4; Tablero: 3; Derechos de los accionistas: 4; Compensación: 5.
